JP2887617B2 - Method for producing phosphatidylcholine - Google Patents
Method for producing phosphatidylcholineInfo
- Publication number
- JP2887617B2 JP2887617B2 JP21791790A JP21791790A JP2887617B2 JP 2887617 B2 JP2887617 B2 JP 2887617B2 JP 21791790 A JP21791790 A JP 21791790A JP 21791790 A JP21791790 A JP 21791790A JP 2887617 B2 JP2887617 B2 JP 2887617B2
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- reaction
- gpc
- phosphatidylcholine
- acid anhydride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 title claims description 15
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 150000004665 fatty acids Chemical class 0.000 claims description 32
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 30
- 229930195729 fatty acid Natural products 0.000 claims description 30
- 239000000194 fatty acid Substances 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000003054 catalyst Substances 0.000 claims description 10
- 239000000010 aprotic solvent Substances 0.000 claims description 9
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 claims description 4
- 239000008777 Glycerylphosphorylcholine Substances 0.000 claims 1
- 229960004956 glycerylphosphorylcholine Drugs 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 23
- 235000019441 ethanol Nutrition 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- NGEZPLCPKXKLQQ-VOTSOKGWSA-N (e)-4-(3-methoxyphenyl)but-3-en-2-one Chemical compound COC1=CC=CC(\C=C\C(C)=O)=C1 NGEZPLCPKXKLQQ-VOTSOKGWSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- -1 acyl imidazole Chemical compound 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000004807 desolvation Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 229960004979 fampridine Drugs 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- GKJZMAHZJGSBKD-UHFFFAOYSA-N (10E,12E)-Octadeca-9,11-dienoic acid Natural products CCCCCC=CC=CCCCCCCCCC(O)=O GKJZMAHZJGSBKD-UHFFFAOYSA-N 0.000 description 1
- PSTNFFRYOYCMRS-BSWSSELBSA-N (10E,12E)-heptadeca-10,12-dienoic acid Chemical compound CCCC\C=C\C=C\CCCCCCCCC(O)=O PSTNFFRYOYCMRS-BSWSSELBSA-N 0.000 description 1
- GKJZMAHZJGSBKD-BLHCBFLLSA-N (10e,12e)-octadeca-10,12-dienoic acid Chemical compound CCCCC\C=C\C=C\CCCCCCCCC(O)=O GKJZMAHZJGSBKD-BLHCBFLLSA-N 0.000 description 1
- ADHNUPOJJCKWRT-JLXBFWJWSA-N (2e,4e)-octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCC\C=C\C=C\C(O)=O ADHNUPOJJCKWRT-JLXBFWJWSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- GKJZMAHZJGSBKD-ANYPYVPJSA-N 10-trans-12-cis-linoleic acid Natural products CCCCCC=C\C=C\CCCCCCCCC(O)=O GKJZMAHZJGSBKD-ANYPYVPJSA-N 0.000 description 1
- ADHNUPOJJCKWRT-UHFFFAOYSA-N 2,4-octadecadienoic acid Natural products CCCCCCCCCCCCCC=CC=CC(O)=O ADHNUPOJJCKWRT-UHFFFAOYSA-N 0.000 description 1
- KDYOFXPLHVSIHS-UHFFFAOYSA-N 2-(4-methylphenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=C(C)C=C1 KDYOFXPLHVSIHS-UHFFFAOYSA-N 0.000 description 1
- BBIICLSHDKMRTP-UHFFFAOYSA-N 2-methyl-4-pyrrolidin-1-ylpyridine Chemical compound C1=NC(C)=CC(N2CCCC2)=C1 BBIICLSHDKMRTP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IPDCWRQMGYMIJZ-UHFFFAOYSA-N 3-butyl-4-pyrrolidin-1-ylpyridine Chemical compound CCCCC1=CN=CC=C1N1CCCC1 IPDCWRQMGYMIJZ-UHFFFAOYSA-N 0.000 description 1
- RGUKYNXWOWSRET-UHFFFAOYSA-N 4-pyrrolidin-1-ylpyridine Chemical compound C1CCCN1C1=CC=NC=C1 RGUKYNXWOWSRET-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- ABCNOPCASVAZFN-UHFFFAOYSA-N nonadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCCC=CC=CC(O)=O ABCNOPCASVAZFN-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WVJVHUWVQNLPCR-UHFFFAOYSA-N octadecanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCC WVJVHUWVQNLPCR-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000005471 saturated fatty acid group Chemical group 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明はホスファチジルコリンの新規な製造法に関す
る。The present invention relates to a novel method for producing phosphatidylcholine.
大豆、卵黄等に含まれるレシチンは乳化性を有し、食
品、化粧品、塗料等の乳化剤として広く利用されてい
る。またレシチンの生理活性作用に着目し、機能性食
品、医薬品等への応用が進められている。さらにレシチ
ンを含むリン脂質を水に分散すると、2分子膜構造の閉
鎖小胞体であるリポソームが形成され、このリポソーム
は薬物送達システムや、臨床診断薬等の素材として有用
である。Lecithin contained in soybeans, egg yolks and the like has emulsifying properties and is widely used as an emulsifier for foods, cosmetics, paints, and the like. In addition, attention has been paid to the physiologically active action of lecithin, and application to functional foods, pharmaceuticals, and the like has been promoted. Furthermore, when a phospholipid containing lecithin is dispersed in water, a liposome, which is a closed vesicle having a bimolecular membrane structure, is formed, and this liposome is useful as a material for a drug delivery system or a clinical diagnostic agent.
この様に有用なレシチンを製造する試み、即ちホスフ
ァチジルコリンの製造法が種々検討され、報告されてい
る。Various attempts have been made to produce useful lecithin, that is, various methods for producing phosphatidylcholine have been studied and reported.
例えばホスファチジルコリンの製造法としては、
(1)グリセロホスホリンコリン(以下「GPC」と略記
する)をアシルイミダゾールでアシル化する方法(Herm
etterら.Chem.Phys.Lipids 28 111(1981))、(2)
N、N−ジメチル−4−アミノピリジン、N、N−ピロ
リジンピリジン等のエステル化触媒を用い、GPCを脂肪
酸無水物でアシル化する方法(特公昭62−9599号公
報)、(3)N、N−ジシクロヘキシルカルボジイミド
等の縮合剤とN、N−ジメチル−4−4アミノピリジン
等のエステル化触媒を用い、GPCを脂肪酸無水物でアシ
ル化する方法(特開昭64−61489号公報)等が知られて
いる。For example, as a method for producing phosphatidylcholine,
(1) A method of acylating glycerophosphorin choline (hereinafter abbreviated as “GPC”) with acyl imidazole (Herm
etter et al. Chem. Phys. Lipids 28 111 (1981)), (2)
A method of acylating GPC with a fatty acid anhydride using an esterification catalyst such as N, N-dimethyl-4-aminopyridine, N, N-pyrrolidinepyridine (Japanese Patent Publication No. 62-9599), (3) N, A method of acylating GPC with a fatty acid anhydride using a condensing agent such as N-dicyclohexylcarbodiimide and an esterification catalyst such as N, N-dimethyl-4-4aminopyridine (Japanese Patent Application Laid-Open No. 64-61489). Are known.
しかしながら、従来知られているこれらの製造法には
種々の問題点がある。However, these conventionally known production methods have various problems.
例えば(1)の方法は、飽和脂肪酸残基以外の脂肪酸
残基を有するホスファチジルコリンを製造することがで
きず、反応熱の制御が困難で反応に長時間を要し、収率
も低い。(2)の方法はGPCを担体に担持させ、これを
脂肪酸無水物と接触させて反応するものであるが、GPC
を担体に担持させる操作、反応後の担体の分離操作等に
複雑な工程を必要とし、収率も低い。(3)の方法は粉
砕したGPCを脂肪酸無水物に添加するか、もしくは脂肪
酸無水物中でGPCを微粉砕した後反応するもので、GPCが
粉末状であるため脂肪酸無水物との接触が悪く、反応が
遅いという欠点がある。For example, the method (1) cannot produce a phosphatidylcholine having a fatty acid residue other than the saturated fatty acid residue, it is difficult to control the heat of reaction, it takes a long time for the reaction, and the yield is low. In the method (2), GPC is supported on a carrier, and the GPC is contacted with a fatty acid anhydride to react.
Complicated steps are required for the operation of supporting the carrier on the carrier and the separating operation of the carrier after the reaction, and the yield is low. In the method (3), the pulverized GPC is added to the fatty acid anhydride, or the GPC is finely pulverized in the fatty acid anhydride and reacted. Since the GPC is in powder form, the contact with the fatty acid anhydride is poor. However, there is a disadvantage that the reaction is slow.
以上述べた様に従来の方法では、GPCにアシル基を導
入するに際し、GPCとアシル基を導入する原料とが混融
せず、従って反応速度が極めて遅くなり、反応に長時間
を要し、かつ収率が低いという欠点があった。As described above, in the conventional method, when introducing an acyl group into GPC, the GPC and the raw material for introducing the acyl group do not mix with each other, so that the reaction rate becomes extremely slow, and the reaction takes a long time, Further, there is a drawback that the yield is low.
本発明は上記の問題点に着目し、なされたもので、GP
Cと脂肪酸無水物とを用い、簡単な操作で、しかも反応
時間が短く、ホスファチジルコリンを高収率で製造する
ことのできる方法を提供することを要旨とする。The present invention has been made in view of the above problems,
It is an object of the present invention to provide a method capable of producing phosphatidylcholine in a high yield with a simple operation and a short reaction time using C and a fatty acid anhydride.
本発明者らは上記課題を解決するため鋭意研究を行な
った結果、特定の溶媒を組み合わせて用いることによ
り、GPCを脂肪酸無水物に極めて微細に分散することが
でき、両者の接触面積が大きくて反応が速みやかに進行
し、ホスファチジルコリンを高収率で得る方法を見いだ
し本発明に到った。The present inventors have conducted intensive studies to solve the above problems, and as a result, by using a specific solvent in combination, GPC can be extremely finely dispersed in fatty acid anhydride, and the contact area between the two is large. The reaction progressed promptly, and a method for obtaining phosphatidylcholine in high yield was found, and the present invention was reached.
即ち本発明は、GPCと脂肪酸無水物とを低級アルコー
ルに溶解した後、低級アルコールを留去し、次いで非プ
ロトン性溶媒と塩基性触媒とを加えて反応するホスファ
チジルコリンの製造法である。That is, the present invention is a method for producing phosphatidylcholine in which GPC and a fatty acid anhydride are dissolved in a lower alcohol, the lower alcohol is distilled off, and then an aprotic solvent and a basic catalyst are added and reacted.
本発明に用いるGPCは下記一般式で表わされ、 大豆、卵黄、その他動植物油脂等から分離し、精製し
たレシチンを常法に従い加水分解して得られるGPCが挙
げられる。GPC used in the present invention is represented by the following general formula, GPC obtained by hydrolyzing lecithin, which has been separated from soybean, egg yolk, other animal and vegetable fats and oils, and purified in accordance with a conventional method, may be mentioned.
本発明に用いる脂肪酸無水物は、一般式(RCO)2Oで
表わされる(式中Rは炭素数9〜21の飽和炭化水素基も
しくは不飽和炭化水素基、又は芳香族炭化水素基を示
す)脂肪酸無水物が挙げられ、脂肪酸と脂肪酸塩化物と
を縮合する方法、脂肪酸塩と脂肪酸塩化物とを反応させ
る方法、脂肪酸を脱水する方法等の常法に従って得られ
た脂肪酸無水物を用いることができる。The fatty acid anhydride used in the present invention is represented by the general formula (RCO) 2 O, wherein R represents a saturated or unsaturated hydrocarbon group having 9 to 21 carbon atoms, or an aromatic hydrocarbon group. Fatty acid anhydrides may be used, and it is possible to use a fatty acid anhydride obtained according to a conventional method such as a method of condensing a fatty acid and a fatty acid chloride, a method of reacting a fatty acid salt with a fatty acid chloride, and a method of dehydrating a fatty acid. it can.
上記脂肪酸無水物を構成する脂肪酸としては、ラウリ
ン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ア
ラキジン酸、ベヘン酸、ミリストレイン酸、パルミトレ
イン酸、オレイン酸、エライジン酸、リノール酸、リノ
レイン酸、アラキドン酸、エイコサペンタエン酸、ドコ
サヘキサエン酸、10,12−オクタデカジエン酸、2,4−オ
クタデカジエン酸、10,12−ヘプタデカジエン酸、2,4−
ノナデカジエン酸、P−メチルフェニルプロピオン酸、
P−ビニルフェニルヘキサン酸等が挙げられ、これらの
脂肪酸残基は単独もしくは組み合わせて用いられる。The fatty acids constituting the fatty acid anhydride include lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, myristoleic acid, palmitoleic acid, oleic acid, elaidic acid, linoleic acid, linoleic acid, and arachidonic acid. , Eicosapentaenoic acid, docosahexaenoic acid, 10,12-octadecadienoic acid, 2,4-octadecadienoic acid, 10,12-heptadecadienoic acid, 2,4-
Nonadecadienoic acid, P-methylphenylpropionic acid,
P-vinylphenylhexanoic acid and the like are mentioned, and these fatty acid residues are used alone or in combination.
本発明に用いられる低級アルコールとしては、メチル
アルコール、エチルアルコール、プロピルアルコール、
イソプロピルアルコール、ブチルアルコール、sec−ブ
チルアルコール、tert−ブチルアルコール、アミルアル
コール、イソアミルアルコール、ヘキシルアルコール、
ヘプチルアルコール等が挙げられ、メチルアルコール、
エチルアルコールが好ましい。As the lower alcohol used in the present invention, methyl alcohol, ethyl alcohol, propyl alcohol,
Isopropyl alcohol, butyl alcohol, sec-butyl alcohol, tert-butyl alcohol, amyl alcohol, isoamyl alcohol, hexyl alcohol,
Heptyl alcohol and the like, methyl alcohol,
Ethyl alcohol is preferred.
本発明に用いられる非プロトン性溶媒としては、脂肪
酸無水物及び塩基性触媒を溶解または分散することので
きる非プロトン性の溶媒が好ましく、例えばn−ペンタ
ン、n−ヘキサン、イソヘキサン、n−ヘプタン、n−
オクタン、イソオクタン、石油エーテル、シクロヘキサ
ン、ベンゼン、トルエン、キシレン、塩化メチレン、ク
ロロホルム、四塩化炭素、塩化エチレン、トリクロルエ
タン、クロルベンゼン、ジメチルスルホキシド、ジメチ
ルホルムアミド、ジメチルアセトアミド、n−メチルピ
ロリドン、ヘキサメチルホスホンアミド、メチルエチル
ケトン等が挙げられ、これらは単独もしくは2種以上を
混合して用いることができる。The aprotic solvent used in the present invention is preferably an aprotic solvent capable of dissolving or dispersing the fatty acid anhydride and the basic catalyst, for example, n-pentane, n-hexane, isohexane, n-heptane, n-
Octane, isooctane, petroleum ether, cyclohexane, benzene, toluene, xylene, methylene chloride, chloroform, carbon tetrachloride, ethylene chloride, trichloroethane, chlorobenzene, dimethyl sulfoxide, dimethylformamide, dimethylacetamide, n-methylpyrrolidone, hexamethylphosphonamide , Methyl ethyl ketone and the like, and these can be used alone or in combination of two or more.
本発明に用いられる塩基性触媒としては、N,N−ジメ
チル−4−アミノピリジン、N,N−ジメチル−4−アミ
ノ−2−メチルピリジン,N,N−ジエチル−4−アミノピ
リジン、N,N−ジブチル−4−アミノ−3−エチルピリ
ジン、4−ピロリジノピリジン、4−ピロリジノ−2−
メチルピリジン、4−ピロリジノ−3−ブチルピリジ
ン、ピリジン、トリエチルアミン、トリブチルアミン、
ジイソプロピルエチルアミン、トリオクチルアミン、ト
リプロピルアミン、トリイソプロピルアミン等が挙げら
れ、これらは単独もしくは混合して用いることができ
る。As the basic catalyst used in the present invention, N, N-dimethyl-4-aminopyridine, N, N-dimethyl-4-amino-2-methylpyridine, N, N-diethyl-4-aminopyridine, N, N-dibutyl-4-amino-3-ethylpyridine, 4-pyrrolidinopyridine, 4-pyrrolidino-2-
Methylpyridine, 4-pyrrolidino-3-butylpyridine, pyridine, triethylamine, tributylamine,
Examples thereof include diisopropylethylamine, trioctylamine, tripropylamine, and triisopropylamine, and these can be used alone or as a mixture.
本発明によりホスファチジルコリンを製造するには、
まずGPC1モルと脂肪酸無水物1〜2モルとを低級アルコ
ールに溶解する。低級アルコールの使用量は、GPCと脂
肪酸無水物とを溶解できる量であれば良く、両者の合計
量に対し、重量で1〜5倍量が好ましい。上記溶解の操
作において、各原料の添加順位はいずれが先であっても
良く、また溶解に要する撹拌力は少なくて良く、通常の
撹拌機を用いることができる。To produce phosphatidylcholine according to the present invention,
First, 1 mol of GPC and 1 to 2 mol of fatty acid anhydride are dissolved in a lower alcohol. The used amount of the lower alcohol may be any amount that can dissolve the GPC and the fatty acid anhydride, and is preferably 1 to 5 times the weight of the total amount of both. In the above-mentioned dissolving operation, the order of addition of each raw material may be any order, and the stirring power required for dissolving may be small, and an ordinary stirrer can be used.
GPCと脂肪酸無水物とが低級アルコールに溶解し、均
一となったら次に低級アルコールを留去する。低級アル
コールの留去は加熱下に蒸留するが、減圧下もしくは減
圧下に加熱して行なうことができ、加熱する場合GPC及
び脂肪酸無水物の変質を防ぐため100℃以下にて行なう
ことが望ましい。ここで低級アルコールを留去してもGP
Cおよび脂肪酸無水物のどちらも凝集することなく、い
ずれか一方が他方に微細に分散した30℃で固体状もしく
は液体状の混合物が得られる。When GPC and fatty acid anhydride are dissolved in the lower alcohol and become uniform, the lower alcohol is then distilled off. Distillation of the lower alcohol is carried out by heating, but it can be carried out under reduced pressure or by heating under reduced pressure. In the case of heating, it is preferable to carry out the heating at a temperature of 100 ° C. or lower in order to prevent deterioration of GPC and fatty acid anhydride. Even if lower alcohol is distilled off here, GP
Neither C nor fatty acid anhydride is aggregated, and a solid or liquid mixture is obtained at 30 ° C. in which either one is finely dispersed in the other.
次に上記混合物に非プロトン性溶媒を加える。非プロ
トン性溶媒を加えると、脂肪酸無水物は非プロトン性溶
媒に溶解し、GPCはその中に50ミクロン以下、主に20ミ
クロン以下の微細な粒子の状態で分散した分散液が得ら
れる。ここに用いる非プロトン性溶媒の量はGPCと脂肪
酸無水物との合計量に対し、重量で3倍量以上が好まし
い。Next, an aprotic solvent is added to the above mixture. When the aprotic solvent is added, the fatty acid anhydride is dissolved in the aprotic solvent, and a dispersion is obtained in which GPC is dispersed in the form of fine particles of 50 μm or less, mainly 20 μm or less. The amount of the aprotic solvent used here is preferably at least 3 times the weight of the total amount of GPC and fatty acid anhydride.
上記分散液に塩基性触媒を加え、アシル化反応を行な
う。塩基性触媒の添加量はGPCに対し1〜5重量%が好
ましい。アシル化反応はチッ素ガス、ヘリウムガス、ア
ルゴンガス等の不活性ガスの気流下、撹拌しながら0〜
70℃で2〜12時間行なう。反応の進行に従い、分散液は
白濁の状態から透明な状態となり、4〜12時間で反応が
完結する。An acylation reaction is performed by adding a basic catalyst to the dispersion. The addition amount of the basic catalyst is preferably 1 to 5% by weight based on GPC. The acylation reaction is carried out under a flow of an inert gas such as nitrogen gas, helium gas, argon gas or the like while stirring.
Perform at 70 ° C. for 2-12 hours. As the reaction proceeds, the dispersion changes from a cloudy state to a transparent state, and the reaction is completed in 4 to 12 hours.
反応終了後、反応液を濃縮し、アセトンで洗浄を行な
って塩基性触媒を除去し、アセトン不溶部をメタノール
/クロロホルム系溶媒に溶解し、シリカゲルカラムを用
いて分離精製し、高純度のホスファチジルコリンを得る
ことができる。After completion of the reaction, the reaction solution was concentrated, washed with acetone to remove the basic catalyst, the acetone-insoluble portion was dissolved in a methanol / chloroform solvent, and separated and purified using a silica gel column to obtain high-purity phosphatidylcholine. Obtainable.
得られるホスファチジルコリンは下記一般式 (式中、Rは反応原料として用いた脂肪酸無水物の脂肪
酸残基に同じ)で表わされる構造を有し、食品、化粧
品、塗料等の乳化剤、医薬品におけるリポソームとして
の薬物運搬体、人工血液、人工細胞等への応用、リン脂
質を薄膜として用いる絶縁性膜、リン脂質の人工膜をフ
ィルターに吸着させた化学センサー等に用いることがで
きる。The resulting phosphatidylcholine has the following general formula (Wherein, R is the same as the fatty acid residue of the fatty acid anhydride used as a reaction raw material), and has an emulsifier for food, cosmetics, paint, etc., a drug carrier as a liposome in pharmaceuticals, artificial blood, It can be applied to artificial cells and the like, an insulating film using a phospholipid as a thin film, a chemical sensor having an artificial phospholipid film adsorbed on a filter, and the like.
以下実施例により本発明をさらに詳細に説明するが、
本発明はその要旨を超えない限り、これらに限定されな
い。Hereinafter, the present invention will be described in more detail with reference to Examples.
The present invention is not limited to these without departing from the gist thereof.
実施例1 300mlの撹拌機付きフラスコに、L−α−グリセロホ
スファチジルコリン10g(0.0388モル)、パルミチン酸
無水物21.2g(0.0427モル)及びメタノール30gを仕込
み、40℃に加熱し溶解した。溶解後、減圧下70℃でメタ
ノールを留去し、留去後さらに同温度で5時間減圧を行
ない、乾燥した。乾燥後、脱水乾燥したクロロホルム10
0mlを加え、緩く撹拌すると白濁した溶液が得られた。
次にこの溶液に4−ジメチルアミノピリジン4.7g(0.04
27モル)を加え、チッ素ガス気流下、撹拌しながら50℃
で5時間、アシル化反応を行なった。反応終了後、減圧
下、40℃でクロロホルムを留去し、次いでアセトン100m
lを加え、1時間撹拌し、生成した結晶を濾別し、乾燥
して29.5gの結晶を得た。得られた結晶をクロロホルム
/メタノール=75/25の溶剤60mlに溶解し、シリカゲル
カラムに吸着した後、クロロホルム/メタノール/水=
65/25/4の溶離剤を用いて溶離し、溶離液を濃縮して、
白色の結晶28.5gを得た。得られた結晶は分析の結果、
L−β,γ−ジパルミトイル−α−ホスファチジルコリ
ンであり、収率は95%であった。Example 1 A 300 ml flask equipped with a stirrer was charged with 10 g (0.0388 mol) of L-α-glycerophosphatidylcholine, 21.2 g (0.0427 mol) of palmitic anhydride and 30 g of methanol, and heated to 40 ° C. to dissolve. After dissolution, methanol was distilled off at 70 ° C. under reduced pressure. After the distillation, the pressure was further reduced at the same temperature for 5 hours, followed by drying. After drying, dehydrated and dried chloroform 10
0 ml was added and stirred gently to give a cloudy solution.
Then 4.7 g of 4-dimethylaminopyridine (0.04
27 mol) and stirred at 50 ° C under nitrogen gas flow.
For 5 hours. After completion of the reaction, chloroform was distilled off under reduced pressure at 40 ° C, and then acetone 100m
l, and the mixture was stirred for 1 hour. The generated crystals were separated by filtration and dried to obtain 29.5 g of crystals. The obtained crystals were dissolved in 60 ml of a solvent of chloroform / methanol = 75/25 and adsorbed on a silica gel column.
Elute with 65/25/4 eluent, concentrate the eluent,
28.5 g of white crystals were obtained. As a result of the analysis,
L-β, γ-dipalmitoyl-α-phosphatidylcholine, and the yield was 95%.
得られた結晶のIR、NMR、TLCの各分析結果を、シグマ
社製L−β,γ−ジパルミトイル−α−ホスファチジル
コリン標準試薬(純度99%)の分析結果と比較したとこ
ろよく一致した。The results of IR, NMR, and TLC analysis of the obtained crystals were compared well with those of L-β, γ-dipalmitoyl-α-phosphatidylcholine standard reagent (purity 99%) manufactured by Sigma.
実施例2 500mlの撹拌機付きフラスコに、L−α−グリセロホ
スホリルコリン20g(0.0776モル)、ステアリン酸無水
物44.2g(0.0802モル)及びメタノール100gを仕込み、5
0℃に加熱し、溶解し、緩速撹拌下に実施例1と同様に
してメタノールを留去し、残渣に脱水乾燥したクロロホ
ルム200mlとジメチルスルホオキシド50mlを加えて溶解
した。得られた溶液にN,N−ジメチル−4−アミノピリ
ジン18.9g(0.155モル)を加え、チッ素ガス気流下、室
温で8時間アシル化反応を行なった。反応終了後、実施
例1と同様に、脱溶媒、アセトン精製、シリカゲルカラ
ム(溶剤クロロホルム/メタノール=75/25、溶離剤
クロロホルム/メタノール/水=65/28/5)により精製
して、L−β,γ−ジステアロイル−α−ホスファチジ
ルコリンの白色結晶55.8g(収率98%)を得た。Example 2 A 500 ml flask equipped with a stirrer was charged with 20 g (0.0776 mol) of L-α-glycerophosphorylcholine, 44.2 g (0.0802 mol) of stearic anhydride and 100 g of methanol.
The mixture was heated to 0 ° C. for dissolution, and methanol was distilled off under slow stirring in the same manner as in Example 1. The residue was dissolved by adding 200 ml of dehydrated and dried chloroform and 50 ml of dimethyl sulfoxide. 18.9 g (0.155 mol) of N, N-dimethyl-4-aminopyridine was added to the obtained solution, and an acylation reaction was carried out at room temperature for 8 hours under a nitrogen gas stream. After completion of the reaction, desolvation, acetone purification, and silica gel column (solvent chloroform / methanol = 75/25, eluent
Purification with chloroform / methanol / water = 65/28/5) gave 55.8 g (98% yield) of white crystals of L-β, γ-distearoyl-α-phosphatidylcholine.
実施例3 300mlの撹拌機付きフラスコに、L−α−グリセロホ
スホリルコリン10g(0.0388モル)、エイコサペンタエ
ン酸無水物25.8g(0.044モル)及びメタノール100gを仕
込み、25℃に加熱し溶解した。緩速撹拌下、減圧下25℃
でメタノールを留去し、次いで20℃で5時間減圧下に乾
燥を行ない、残渣に脱水乾燥したクロロホルム150mlを
加えて溶解した。得られた溶液に4−ジメチルアミノピ
リジン9.4g(0.0854モル)を加え、チッ素ガス気流下、
室温で12時間、反応を行なった。反応終了後、実施例1
と同様に、脱溶媒、アセトン精製、シリカゲルカラム
(溶媒 クロロホルム/メタノール=75/25、溶離剤
クロロホルム/メタノール/水=65/25/4)により精製
して、L−β,γ−ジエイコサペンタエノイルホスファ
チジルコリンの白色結晶28g(収率93%)を得た。Example 3 A 300 ml flask with a stirrer was charged with 10 g (0.0388 mol) of L-α-glycerophosphorylcholine, 25.8 g (0.044 mol) of eicosapentaenoic anhydride and 100 g of methanol, and heated to 25 ° C. to dissolve. 25 ° C under reduced pressure with slow stirring
Then, methanol was distilled off, followed by drying under reduced pressure at 20 ° C. for 5 hours. The residue was dissolved by adding 150 ml of dehydrated and dried chloroform. To the resulting solution was added 9.4 g (0.0854 mol) of 4-dimethylaminopyridine, and under a stream of nitrogen gas,
The reaction was performed at room temperature for 12 hours. After completion of the reaction, Example 1
Solvent removal, acetone purification, silica gel column (solvent chloroform / methanol = 75/25, eluent
Purification with chloroform / methanol / water = 65/25/4) yielded 28 g of white crystals of L-β, γ-diicosapentaenoylphosphatidylcholine (93% yield).
比較例1 300mlの撹拌機付きフラスコに、50〜100メッシュに粉
砕したL−α−グリセロホスホリルコリン10g(0.0388
モル)、パルミチン酸無水物21.2g(0.0427モル)、脱
水乾燥したクロロホルム150ml、4−ジメチルアミノピ
リジン9.5g(0.0776モル)を加え、チッ素ガス気流下、
50℃で急速撹拌を行ないながら10時間、反応を行なっ
た。反応終了後、実施例1と同様に、脱溶媒、アセトン
精製、シリカゲルカラムによる精製を行ない、L−β,
γ−ジパルミトイル−α−ホスファチジルコリンの白色
結晶13.5gを得た。収率は45%であった。Comparative Example 1 In a 300 ml flask equipped with a stirrer, 10 g of L-α-glycerophosphorylcholine (0.0388
Mol), 21.2 g (0.0427 mol) of palmitic anhydride, 150 ml of dehydrated and dried chloroform, and 9.5 g (0.0776 mol) of 4-dimethylaminopyridine, and under a nitrogen gas stream,
The reaction was carried out at 50 ° C. for 10 hours with rapid stirring. After completion of the reaction, desolvation, acetone purification, and silica gel column purification were carried out in the same manner as in Example 1 to obtain L-β,
13.5 g of white crystals of γ-dipalmitoyl-α-phosphatidylcholine were obtained. The yield was 45%.
以上説明した様に、本発明はGPCと脂肪酸無水物を反
応してホスファチジルコリンを製造する方法において、
反応原料を低級アルコールに溶解して均一に混合した
後、低級アルコールを留去し、非プロトン性溶媒、塩基
性触媒を加えて反応を行なうもので、脂肪酸無水物を溶
解した非プロトン性溶媒の溶液中にGPCが極めて微細な
状態に分散しているため、従来の方法と比較して短時間
で高い反応率の反応を行なうことができ、また担体等を
使用することがないので、反応後の精製が容易となり、
かつ純度の高いホスファチジルコリンを高収率で得るこ
とができる。また本発明の方法はGPCを分散する操作が
簡単なため、複雑な工程や大規模や製造装置等を必要と
せず、経済性に優れる等の効果を有する。As described above, the present invention relates to a method for producing phosphatidylcholine by reacting GPC with a fatty acid anhydride,
After the reaction raw materials are dissolved in lower alcohol and uniformly mixed, the lower alcohol is distilled off, and the reaction is performed by adding an aprotic solvent and a basic catalyst. Since GPC is dispersed in a very fine state in the solution, it is possible to carry out a reaction with a high reaction rate in a short time as compared with the conventional method, and since no carrier is used, the reaction after Purification becomes easier,
In addition, highly pure phosphatidylcholine can be obtained in a high yield. In addition, the method of the present invention has effects such as excellent economical efficiency without the need for complicated steps, large scale, manufacturing equipment, etc., because the operation of dispersing GPC is simple.
Claims (1)
とを低級アルコールに溶解した後、低級アルコールを留
去し、次いで非プロトン性溶媒と塩基性触媒とを加えて
反応することを特徴とするホスファチジルコリンの製造
法。1. A method for producing phosphatidylcholine, comprising dissolving glycerophosphorylcholine and a fatty acid anhydride in a lower alcohol, distilling the lower alcohol, and then reacting by adding an aprotic solvent and a basic catalyst. Law.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21791790A JP2887617B2 (en) | 1990-08-17 | 1990-08-17 | Method for producing phosphatidylcholine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21791790A JP2887617B2 (en) | 1990-08-17 | 1990-08-17 | Method for producing phosphatidylcholine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0499784A JPH0499784A (en) | 1992-03-31 |
| JP2887617B2 true JP2887617B2 (en) | 1999-04-26 |
Family
ID=16711765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21791790A Expired - Fee Related JP2887617B2 (en) | 1990-08-17 | 1990-08-17 | Method for producing phosphatidylcholine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2887617B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
| USRE40546E1 (en) * | 1996-05-01 | 2008-10-21 | Scarista, Ltd. | 1,3-Propane diol esters and ethers and methods for their use in drug delivery |
| NZ306510A (en) * | 1995-05-01 | 1999-05-28 | Scotia Holdings Plc | Niacin derivatives which include a fatty acid or fatty acid alcohol residue and their use in medicaments and skin care compositions |
-
1990
- 1990-08-17 JP JP21791790A patent/JP2887617B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0499784A (en) | 1992-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2887617B2 (en) | Method for producing phosphatidylcholine | |
| JP2884105B2 (en) | Method for producing phosphatidylcholine | |
| JPS6320439B2 (en) | ||
| CN103435676B (en) | Phytosterol phosphorylation amino-acid ester derivative and synthetic method thereof | |
| CN107540538B (en) | Composition, reaction system and method for preparing 5-methyl isophthalic acid | |
| JP2546289B2 (en) | Method for producing synthetic lecithin | |
| JPS629599B2 (en) | ||
| JPS6185396A (en) | Preparation of phosphatidylcholine | |
| JPS6216439A (en) | Production of phosphatidylcholine | |
| JPS6169786A (en) | Separation purification of sugar ester | |
| US4008270A (en) | Process for preparing 2-(substituted phenyl)propionic acids | |
| EP0515283A1 (en) | N-alkyl, N-acetyloseamines, their preparation and their use particularly as surface-active or solutisation agents for the isolation of membrane proteins | |
| US3784562A (en) | Methyl acetoacetic ester enamine of d-2-(1,4-cyclohexadien-1-yl)glycine, sodium salt-dimethylformamide adduct | |
| JPH01211547A (en) | Purification of acyl halide | |
| JPH0940632A (en) | Diacylglycerol derivative | |
| JPS61275287A (en) | Production of synthetic phosphatidylcholine | |
| JP2618759B2 (en) | Glycerol derivatives | |
| JPH01172395A (en) | Production of phosphatidyl choline | |
| JPS61158990A (en) | Production of glycerophosphorylcholine | |
| CN119823174A (en) | Lysophosphatidyl Process for the preparation of choline | |
| SU690002A1 (en) | Method of preparing 4-methoxy-1,2-naphthoquinone | |
| JPS61207396A (en) | Production of phosphatidylcholine | |
| JPS6284092A (en) | Lecithin having good water dispersibility | |
| JPS5896032A (en) | Method for producing polyprenyl compounds or mixtures thereof | |
| JP2002275187A (en) | Method for producing phosphatidylcholine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |